[Urticaria after subcutaneous administration of Insulatard].
Hruz
P
P
Medizinische Poliklinik, Universitätsspital Basel.
Stöckli
R
R
Bircher
A
A
D003692:Delayed-Action Preparations; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000209:etiology*; D007073:Immunoglobulin E / Q000097:blood; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives; D000069057:Insulin Detemir; D007336:Insulin, Isophane; D049528:Insulin, Long-Acting / Q000009:adverse effects* / Q000627:therapeutic use; D061386:Insulin, Regular, Human; D007428:Intradermal Tests; D000068880:Isophane Insulin, Human; D008297:Male; D008875:Middle Aged; D014581:Urticaria / Q000139:chemically induced*
D003692:Delayed-Action Preparations; D007328:Insulin; D049528:Insulin, Long-Acting; D061386:Insulin, Regular, Human; D000068880:Isophane Insulin, Human; D007073:Immunoglobulin E; D000069057:Insulin Detemir; D007336:Insulin, Isophane